Imbruvica

{
  "id": "MLC-T-ONC-004181",
  "term": "Imbruvica",
  "field": "Oncology and biomedicine",
  "definition": "A drug used alone or with other drugs to treat adults with chronic lymphocytic leukemia, small lymphocytic lymphoma, or Waldenstrom macroglobulinemia (a type of non-Hodgkin lymphoma). It is also used to treat adults and children aged 1 year and older with chronic graft versus host disease. It is also being studied in the treatment of other types of cancer. Imbruvica blocks a protein called BTK, which may help keep cancer cells from growing. It may also lower the body’s immune response. Imbruvica is a type of tyrosine kinase inhibitor. Also called ibrutinib.",
  "synonyms": [
    "ibrutinib"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/imbruvica/"
}